Imeik Technology Development
Imeik Technology Development Co Ltd is a Chinese multinational medical technology and biopharmaceutical enterprise specializing in the research, development, and manufacturing of biomedical materials, medical aesthetic products, dermal fillers, and regenerative medicine solutions. The company produces advanced hyaluronic acid-based dermal fillers, facial implantation materials, and medical aesthetic injectables supplied to accredited medical clinics, plastic surgery hospitals, and healthcare practitioners across China. Its core business operations encompass biomedical material formulation, medical aesthetic product manufacturing, clinical trial execution, and global wholesale distribution. Revenue is derived directly from the global wholesale sale of dermal fillers and medical aesthetic injectables. Imeik Technology Development holds a dominant market position in medical aesthetic biomaterials and dermal filler manufacturing in China. The company is headquartered in Beijing, China, and its shares trade on the Shenzhen Stock Exchange.
4 of the funds FundTelligence covers report a position in Imeik Technology Development.
- Legal name
- Imeik Technology Development Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 4
Funds holding Imeik Technology Development
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.0 % (full portfolio disclosed, June 2026)